These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17989930)

  • 1. An atomistic model of passive membrane permeability: application to a series of FDA approved drugs.
    Kalyanaraman C; Jacobson MP
    J Comput Aided Mol Des; 2007 Dec; 21(12):675-9. PubMed ID: 17989930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?
    Swift RV; Amaro RE
    Chem Biol Drug Des; 2013 Jan; 81(1):61-71. PubMed ID: 23066853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing physical models of passive membrane permeation.
    Leung SS; Mijalkovic J; Borrelli K; Jacobson MP
    J Chem Inf Model; 2012 Jun; 52(6):1621-36. PubMed ID: 22621168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
    Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
    J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting a Drug's Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data.
    Bennion BJ; Be NA; McNerney MW; Lao V; Carlson EM; Valdez CA; Malfatti MA; Enright HA; Nguyen TH; Lightstone FC; Carpenter TS
    J Phys Chem B; 2017 May; 121(20):5228-5237. PubMed ID: 28453293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers.
    Lanevskij K; Didziapetris R
    J Pharm Sci; 2019 Jan; 108(1):78-86. PubMed ID: 30321548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A corneal-PAMPA-based in silico model for predicting corneal permeability.
    Vincze A; Dargó G; Rácz A; Balogh GT
    J Pharm Biomed Anal; 2021 Sep; 203():114218. PubMed ID: 34166924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Passive Membrane Permeability by Semi-Empirical Method Considering Viscous and Inertial Resistances and Different Rates of Conformational Change and Diffusion.
    Fukunishi Y; Mashimo T; Kurosawa T; Wakabayashi Y; Nakamura HK; Takeuchi K
    Mol Inform; 2020 Jan; 39(1-2):e1900071. PubMed ID: 31609549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Membrane Partitioning Simulations To Predict Permeability of Forty-Nine Drug-Like Molecules.
    Dickson CJ; Hornak V; Bednarczyk D; Duca JS
    J Chem Inf Model; 2019 Jan; 59(1):236-244. PubMed ID: 30540467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug permeability prediction using PMF method.
    Meng F; Xu W
    J Mol Model; 2013 Mar; 19(3):991-7. PubMed ID: 23104229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.
    Chen IJ; Taneja R; Yin D; Seo PR; Young D; MacKerell AD; Polli JE
    Mol Pharm; 2006; 3(6):745-55. PubMed ID: 17140262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes.
    Acharya C; Seo PR; Polli JE; Mackerell AD
    Mol Pharm; 2008; 5(5):818-28. PubMed ID: 18710255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.
    Camenisch G; Alsenz J; van de Waterbeemd H; Folkers G
    Eur J Pharm Sci; 1998 Oct; 6(4):317-24. PubMed ID: 9795088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.